{"id":"https://openalex.org/W4410698616","doi":"https://doi.org/10.1186/s13046-025-03421-8","title":"An antibody-drug conjugate targeting soluble and membrane-bound TGF\u03b1 is effective against pancreatic tumors","display_name":"An antibody-drug conjugate targeting soluble and membrane-bound TGF\u03b1 is effective against pancreatic tumors","alternate_titles":[],"publication_year":2025,"publication_date":"2025-05-23","ids":{"openalex":"https://openalex.org/W4410698616","doi":"https://doi.org/10.1186/s13046-025-03421-8","pmid":"https://pubmed.ncbi.nlm.nih.gov/40410803","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12100920"},"language":"en","primary_location":{"id":"doi:10.1186/s13046-025-03421-8","doi":"https://doi.org/10.1186/s13046-025-03421-8","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13046-025-03421-8","pdf_url":"https://jeccr.biomedcentral.com/counter/pdf/10.1186/s13046-025-03421-8","source":{"id":"https://openalex.org/S33781645","display_name":"Journal of Experimental & Clinical Cancer Research","issn_l":"0392-9078","issn":["0392-9078","1756-9966"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Experimental &amp; Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4410698616"],"child_works_count":8,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jeccr.biomedcentral.com/counter/pdf/10.1186/s13046-025-03421-8","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075550219","display_name":"In\u00e9s Romero-P\u00e9rez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"In\u00e9s Romero-P\u00e9rez","raw_affiliation_strings":["Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer- CSIC and CIBERONC, Campus Miguel de Unamuno, Salamanca, 37007, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer- CSIC and CIBERONC, Campus Miguel de Unamuno, Salamanca, 37007, Spain","institution_ids":["https://openalex.org/I4210158561","https://openalex.org/I4388891778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078363282","display_name":"Juan Carlos Montero","orcid":"https://orcid.org/0000-0003-4773-053X","observed_orcids":["https://orcid.org/0000-0003-4773-053X"]},"institutions":[{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan Carlos Montero","raw_affiliation_strings":["Department of Pathologic Anatomy and IBSAL, Salamanca, Spain","Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer- CSIC and CIBERONC, Campus Miguel de Unamuno, Salamanca, 37007, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathologic Anatomy and IBSAL, Salamanca, Spain","institution_ids":["https://openalex.org/I4210134045"]},{"raw_affiliation_string":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer- CSIC and CIBERONC, Campus Miguel de Unamuno, Salamanca, 37007, Spain","institution_ids":["https://openalex.org/I4210158561","https://openalex.org/I4388891778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125225911","display_name":"M\u00f3nica Redondo-Puente","orcid":"https://orcid.org/0000-0002-3222-9489","observed_orcids":["https://orcid.org/0000-0002-3222-9489"]},"institutions":[{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M\u00f3nica Redondo-Puente","raw_affiliation_strings":["Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer- CSIC and CIBERONC, Campus Miguel de Unamuno, Salamanca, 37007, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer- CSIC and CIBERONC, Campus Miguel de Unamuno, Salamanca, 37007, Spain","institution_ids":["https://openalex.org/I4210158561","https://openalex.org/I4388891778"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mar\u00eda del Carmen G\u00f3mez-Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda del Carmen G\u00f3mez-Garc\u00eda","raw_affiliation_strings":["Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer- CSIC and CIBERONC, Campus Miguel de Unamuno, Salamanca, 37007, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer- CSIC and CIBERONC, Campus Miguel de Unamuno, Salamanca, 37007, Spain","institution_ids":["https://openalex.org/I4210158561","https://openalex.org/I4388891778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001444142","display_name":"Mireia Morell","orcid":"https://orcid.org/0000-0002-1708-0110","observed_orcids":["https://orcid.org/0000-0002-1708-0110"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mireia Morell-Ginest\u00e0","raw_affiliation_strings":["Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge- IDIBELL-ONCOBELL, L'Hospitalet de Llobregat, Barcelona, 08908, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge- IDIBELL-ONCOBELL, L'Hospitalet de Llobregat, Barcelona, 08908, Spain","institution_ids":["https://openalex.org/I4210087039","https://openalex.org/I4210107147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036172060","display_name":"Gabriel Capell\u00e1","orcid":"https://orcid.org/0000-0002-4669-7320","observed_orcids":["https://orcid.org/0000-0002-4669-7320"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Gabriel Capell\u00e1","raw_affiliation_strings":["Centro de Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Madrid, Spain","Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge- IDIBELL-ONCOBELL, L'Hospitalet de Llobregat, Barcelona, 08908, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), Madrid, Spain","institution_ids":["https://openalex.org/I4210158561"]},{"raw_affiliation_string":"Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigaci\u00f3 Biom\u00e8dica de Bellvitge- IDIBELL-ONCOBELL, L'Hospitalet de Llobregat, Barcelona, 08908, Spain","institution_ids":["https://openalex.org/I4210087039","https://openalex.org/I4210107147"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054921200","display_name":"Atanasio Pandiella","orcid":"https://orcid.org/0000-0002-4704-8971","observed_orcids":["https://orcid.org/0000-0002-4704-8971"]},"institutions":[{"id":"https://openalex.org/I4210138819","display_name":"Centro de Investigaci\u00f3n del C\u00e1ncer","ror":"https://ror.org/04rxrdv16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Atanasio Pandiella","raw_affiliation_strings":["Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer- CSIC and CIBERONC, Campus Miguel de Unamuno, Salamanca, 37007, Spain. atanasio@usal.es"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer- CSIC and CIBERONC, Campus Miguel de Unamuno, Salamanca, 37007, Spain. atanasio@usal.es","institution_ids":["https://openalex.org/I4210138819","https://openalex.org/I4210158561","https://openalex.org/I4388891778"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5054921200"],"corresponding_institution_ids":["https://openalex.org/I4210138819","https://openalex.org/I4210158561","https://openalex.org/I4388891778"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":{"value":4190,"currency":"USD","value_usd":4190},"fwci":0.3685,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.51965674,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"44","issue":"1","first_page":"158","last_page":"158"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/transforming-growth-factor-alpha","display_name":"transforming growth factor-alpha","score":0.671999990940094},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.640999972820282},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8539999723434448},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8240000009536743},{"id":"https://openalex.org/keywords/monomethyl-auristatin-f","display_name":"monomethyl auristatin F","score":0.9269999861717224},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.9290000200271606},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5709999799728394},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.6970000267028809},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.8360000252723694}],"concepts":[{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.7732427716255188},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6644140481948853},{"id":"https://openalex.org/C2777996000","wikidata":"https://www.wikidata.org/wiki/Q7130412","display_name":"Pancreatic tumor","level":4,"score":0.514209508895874},{"id":"https://openalex.org/C125555471","wikidata":"https://www.wikidata.org/wiki/Q14908037","display_name":"TGF alpha","level":4,"score":0.5058786273002625},{"id":"https://openalex.org/C118131993","wikidata":"https://www.wikidata.org/wiki/Q423671","display_name":"Transforming growth factor","level":2,"score":0.4746611416339874},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4492928385734558},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.447110652923584},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41334694623947144},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39302459359169006},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3209350109100342},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.28008994460105896},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2349194586277008},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20707827806472778},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.19615617394447327},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08582517504692078}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016211","descriptor_name":"Transforming Growth Factor alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016211","descriptor_name":"Transforming Growth Factor alpha","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016211","descriptor_name":"Transforming Growth Factor alpha","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016211","descriptor_name":"Transforming Growth Factor alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1186/s13046-025-03421-8","doi":"https://doi.org/10.1186/s13046-025-03421-8","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13046-025-03421-8","pdf_url":"https://jeccr.biomedcentral.com/counter/pdf/10.1186/s13046-025-03421-8","source":{"id":"https://openalex.org/S33781645","display_name":"Journal of Experimental & Clinical Cancer Research","issn_l":"0392-9078","issn":["0392-9078","1756-9966"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Experimental &amp; Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:40410803","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40410803","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of experimental & clinical cancer research : CR","raw_type":"Journal Article"},{"id":"pmh:oai:digital.csic.es:10261/400479","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10261/400479","pdf_url":null,"source":{"id":"https://openalex.org/S4306400616","display_name":"DIGITAL.CSIC (Spanish National Research Council (CSIC))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I134820265","host_organization_name":"Consejo Superior de Investigaciones Cient\u00edficas","host_organization_lineage":["https://openalex.org/I134820265"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"pmh:oai:diposit.ub.edu:2445/222222","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2445/222222","pdf_url":null,"source":{"id":"https://openalex.org/S4306401653","display_name":"Dip\u00f2sit Digital de la Universitat de Barcelona (Universitat de Barcelona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I71999127","host_organization_name":"Universitat de Barcelona","host_organization_lineage":["https://openalex.org/I71999127"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Articles publicats en revistes (Institut d'lnvestigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL))","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12100920","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12100920/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Exp Clin Cancer Res","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:5c908590567d4fcdb2e55a95de5599e1","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5c908590567d4fcdb2e55a95de5599e1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Experimental & Clinical Cancer Research, Vol 44, Iss 1, Pp 1-16 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s13046-025-03421-8","doi":"https://doi.org/10.1186/s13046-025-03421-8","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13046-025-03421-8","pdf_url":"https://jeccr.biomedcentral.com/counter/pdf/10.1186/s13046-025-03421-8","source":{"id":"https://openalex.org/S33781645","display_name":"Journal of Experimental & Clinical Cancer Research","issn_l":"0392-9078","issn":["0392-9078","1756-9966"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Experimental &amp; Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1501945255","display_name":null,"funder_award_id":"PID2020-115605RB-I00","funder_id":"https://openalex.org/F4320321837","funder_display_name":"Ministerio de Econom\u00eda y Competitividad"},{"id":"https://openalex.org/G2577884053","display_name":null,"funder_award_id":"CSI146P20","funder_id":"https://openalex.org/F4320328351","funder_display_name":"Junta de Castilla y Le\u00f3n"},{"id":"https://openalex.org/G4510513275","display_name":"Identificaci\u00f3n de nuevas dianas terap\u00e9uticas, preparaci\u00f3n y eficacia antitumoral de anticuerpos conjugados a drogas (ADCs) en c\u00e1ncer de mama triple negativo y c\u00e1ncer de ovario.","funder_award_id":"PI18/00796","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G575504391","display_name":null,"funder_award_id":"EDU/556/2019)","funder_id":"https://openalex.org/F4320328351","funder_display_name":"Junta de Castilla y Le\u00f3n"},{"id":"https://openalex.org/G5879288298","display_name":null,"funder_award_id":"CPII17/00015","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"}],"funders":[{"id":"https://openalex.org/F4320321837","display_name":"Ministerio de Econom\u00eda y Competitividad","ror":"https://ror.org/034900433"},{"id":"https://openalex.org/F4320328325","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017"},{"id":"https://openalex.org/F4320328351","display_name":"Junta de Castilla y Le\u00f3n","ror":"https://ror.org/02s8dab97"},{"id":"https://openalex.org/F4320332150","display_name":"CRIS Cancer Foundation","ror":"https://ror.org/05qdgvk25"},{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4410698616.pdf","grobid_xml":"https://content.openalex.org/works/W4410698616.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W118213103","https://openalex.org/W1570780771","https://openalex.org/W1577001387","https://openalex.org/W1966658428","https://openalex.org/W1969201526","https://openalex.org/W1972036696","https://openalex.org/W1972841107","https://openalex.org/W1982882974","https://openalex.org/W1996830417","https://openalex.org/W1997341361","https://openalex.org/W2019647633","https://openalex.org/W2020180059","https://openalex.org/W2023560058","https://openalex.org/W2040908275","https://openalex.org/W2071607446","https://openalex.org/W2099583536","https://openalex.org/W2101862196","https://openalex.org/W2107441200","https://openalex.org/W2147420866","https://openalex.org/W2153608256","https://openalex.org/W2160152459","https://openalex.org/W2161513275","https://openalex.org/W2415561223","https://openalex.org/W2498228861","https://openalex.org/W2729267899","https://openalex.org/W2797865989","https://openalex.org/W2898368508","https://openalex.org/W2924993030","https://openalex.org/W2934130030","https://openalex.org/W3001369781","https://openalex.org/W3017732155","https://openalex.org/W3196252461","https://openalex.org/W4315754639","https://openalex.org/W4386529421","https://openalex.org/W4390673654","https://openalex.org/W4391248681","https://openalex.org/W4403694618"],"related_works":["https://openalex.org/W3102450133","https://openalex.org/W2887891297","https://openalex.org/W2122742138","https://openalex.org/W2965423477","https://openalex.org/W4389397317","https://openalex.org/W2162424291","https://openalex.org/W4402838605","https://openalex.org/W3179324525","https://openalex.org/W4392401838","https://openalex.org/W3009291261"],"abstract_inverted_index":{"BACKGROUND:":[0],"Pancreatic":[1],"cancer":[2,42,83,192],"is":[3,20,28,64],"one":[4],"of":[5,13,17,24,35,89,125,134,142,189,207,226,256],"the":[6,15,18,33,60,94,100,122,140,176,187,216,230],"most":[7],"difficult":[8],"to":[9,71,157,170],"treat":[10],"neoplasias.":[11],"Because":[12],"that,":[14],"prognosis":[16],"disease":[19],"dismal,":[21],"and":[22,43,99,111,147,253],"identification":[23],"novel":[25],"therapeutic":[26,48,132,245],"approaches":[27],"needed.":[29],"This":[30],"study":[31],"investigates":[32],"role":[34,124],"transforming":[36],"growth":[37],"factor-alpha":[38],"(TGF\u03b1)":[39],"in":[40,52,67,81,127,164,211,223,247],"pancreatic":[41,68,73,82,191,227,248],"its":[44],"potential":[45,133],"as":[46,78,80,174,242],"a":[47,243],"target.":[49],"METHODS:":[50],"Using":[51],"silico":[53],"platforms,":[54],"it":[55],"was":[56,137],"confirmed":[57],"that":[58,114,197],"TGFA,":[59],"gene":[61],"encoding":[62],"TGF\u03b1,":[63],"significantly":[65,117,185],"overexpressed":[66],"adenocarcinomas":[69],"relative":[70],"normal":[72],"tissues.":[74],"In":[75,214],"patient-derived":[76],"xenografts":[77],"well":[79],"cell":[84,119,166,202],"lines,":[85],"multiple":[86],"molecular":[87],"forms":[88],"TGF\u03b1":[90,96,126,136,241],"were":[91],"identified,":[92],"including":[93],"transmembrane":[95],"precursor":[97],"(proTGF\u03b1)":[98],"soluble":[101],"6":[102],"kDa":[103],"mature":[104],"form.":[105],"Functional":[106],"assays":[107],"using":[108],"RNA":[109],"interference":[110],"CRISPR/Cas9":[112],"demonstrated":[113],"TGFA":[115],"knockdown":[116],"impaired":[118],"proliferation,":[120],"reinforcing":[121],"critical":[123],"driving":[128],"tumor":[129,221,235],"growth.":[130,236],"The":[131],"targeting":[135],"evaluated":[138],"through":[139],"development":[141,255],"two":[143],"monoclonal":[144],"antibodies":[145,154,232],"(5F1":[146],"16B10)":[148],"specific":[149],"for":[150],"TGF\u03b1.":[151],"RESULTS:":[152],"These":[153,238],"effectively":[155],"bound":[156],"proTGF\u03b1-expressing":[158],"cells,":[159],"with":[160,205],"minimal":[161],"off-target":[162],"effects":[163],"TGFA-knockout":[165],"lines.":[167],"When":[168],"conjugated":[169],"cytotoxic":[171],"agents":[172],"such":[173],"MMAF,":[175],"resulting":[177],"antibody-drug":[178],"conjugates":[179],"(ADCs)":[180],"exhibited":[181],"potent":[182],"antiproliferative":[183],"activity,":[184],"reducing":[186],"viability":[188],"TGF\u03b1-expressing":[190],"cells.":[193,213],"Mechanistic":[194],"studies":[195],"revealed":[196],"MMAF-loaded":[198],"ADCs":[199,218],"induced":[200],"G2/M":[201],"cycle":[203],"arrest,":[204],"markers":[206],"mitotic":[208],"disruption":[209],"evident":[210],"treated":[212],"vivo,":[215],"TGF\u03b1-targeting":[217],"elicited":[219],"substantial":[220],"regression":[222],"murine":[224],"models":[225],"cancer,":[228,249],"whereas":[229],"unconjugated":[231],"merely":[233],"stabilized":[234],"CONCLUSIONS:":[237],"findings":[239],"highlight":[240],"promising":[244],"target":[246],"supporting":[250],"further":[251],"preclinical":[252],"clinical":[254],"TGF\u03b1-directed":[257],"ADCs.":[258]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4410698616","counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2025-05-24T00:00:00"}
